Evidence map›Paper›PMID 15010544›Full record

ArticleProtein science : a publication of the Protein Society2004

An improved crystal form of Plasmodium falciparum peptide deformylase.

Mark A Robien, Kiet T Nguyen, Abhinav Kumar, Irwin Hirsh, Stewart Turley, Dehua Pei, Wim G J Hol

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Application of protein engineering to enhance crystallizability and improve crystal properties.Acta crystallographica. Section D, Biological crystallography · 2010
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mark A RobienUniversity of Washington, Seattle, Washington 98195, USA.
Kiet T Nguyen
Abhinav Kumar
Irwin Hirsh
Stewart Turley
Dehua Pei
Wim G J Hol
University of Washington · USThe Ohio State University · USHoward Hughes Medical Institute · US

Funding

Peptide Deformylase: Mechanism and Inhibitor DesignR01AI040575 · NIAID · OHIO STATE UNIVERSITY · PI PEI, DEHUA · 1997 to 2005
$1.7M
NIAID NIH HHS AI40575NIAID NIH HHS R01 AI040575
6 · The paper itself

Abstract

An altered version of peptide deformylase from Plasmodium falciparum (PfPDF), the organism that causes the most devastating form of malaria, has been cocrystallized with a synthesized inhibitor that has submicromolar affinity for its target protein. The structure is solved at 2.2 A resolution, an improvement over the 2.8 A resolution achieved during the structural determination of unliganded PfPDF. This represents the successful outcome of modifying the protein construct in order to overcome adverse crystal contacts and other problems encountered in the study of unliganded PfPDF. Two molecules of PfPDF are found in the asymmetric unit of the current structure. The active site of each monomer of PfPDF is occupied by a proteolyzed fragment of the tripeptide-like inhibitor. Unexpectedly, each PfPDF subunit is associated with two nearly complete molecules of the inhibitor, found at a protein-protein interface. This is the first structure of a eukaryotic PDF protein, a potential drug target, in complex with a ligand.

Indexed as

Protein Structure, TertiaryAmidohydrolasesAnimalsBinding SitesCrystallizationCrystallography, X-RayDrug DesignEnzyme InhibitorsPlasmodium falciparumProtein BindingRecombinant ProteinsAmidohydrolasesEnzyme Inhibitorspeptide deformylaseRecombinant Proteins

Identifiers

PMID15010544
PMCPMC2280045
OpenAlexW2167361721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.